Abstract:Background: Hepatic ischemia-reperfusion injury (HIRI) is an unavoidable event associated with liver relevant surgeries. Longchain non-coding RNA, metastasis associated in lung denocarcinama transcript 1 (LncMALAT1) plays important role in tissue ischemia-reperfusion injury. The aim of the study is to characterize the mechanism of LncMALAT1 in the HIRI promotion.Methods: The constructed LncMALAT1 lentivirus was employed to stablish LncMALAT1 up- and down-regulating mice that were all subjected to 70% liver ischemia to create HIRI. The degree of liver tissue injury and hepatocyte apoptosis were visualized using hematoxylin-eosin staining, terminal dexynucleotidyl transferase-mediated 2'-deoxyuridine 5'-triphosphate (dUTP) nick end labeling (TUNEL) method. LncMALAT1 expression was monitored using real-time quantitative reverse transcription polymerase chain reaction (RT-qPCR). Western blot analysis was performed to evaluate autophagy and apoptosis-related proteins expression. Additionally, autophagosome rate was quantified employing transmission electronic microscopy (TEM). Finally, the confocal microscopy was used to observe specific mecherry-green fluorescent protein-microtubule-associated protein 1 light chain 3 (mcherry-GFP-LC3) in LncMALAT1 overexpressed/knockout cell under 1 hour hypoxia/12 hours re-oxygenation condition. The relative rescue experiment was performed using autophagy regulator of 3-methyladenine (3-MA)/rapamycin. The cell survival rate was detected by 3-(4,5-dimethylthiahiazol-2-yl)-2,5-diphenytetrazoliumromide (MTT) assay.Results: Compared to the sham-operated group, both the RNA expression of LncMALAT1 and liver damage were increased in all HIRI groups (p < 0.05). And 6 hours after reperfusion reached to the peak liver damage in line with the RNA expression of LncMALAT1. Upregulated LncMALAT1 in vivo and in vitro, TUNEL positive rate, autophagosome rate and mcherry-GFPLC3 autophagy dots were significantly increased compared to the control group (p < 0.05). The protein expression of Caspase8, Cleaved-Caspase3, microtubule-associated protein 1 light chain 3 (LC3), autophagy related gene 12 (Atg12) were increased (p < 0.05), but the protein expression of sequestosome 1 (SQSTM1/p62), B cell lymphoma-2 (Bcl2), phosphorylated mechanistic target of rapamycin (p-mTOR) were decreased in LncMALAT1 upregulated group liken to the control group (p < 0.05). Nevertheless, downregulation of LncMALAT1 could alleviate the liver damage in vivo and in vitro. Importantly, the LncMALAT1 induced liver autophagy elevation that was responsible for severe apoptosis in HIRI, at least partially.Conclusions: LncMALAT1 enhanced liver autophagy leading to apoptosis aggravation and further hepatic ischemia-reperfusion injury in mice.

The Role of Lncrna MALAT1 in the Regulation of Hepatocyte Proliferation During Liver Regeneration

Malat1-Mediated Tumorigenesis

Long Non-coding RNA MALAT1: A Key Player in Liver Diseases

Long noncoding RNAs associated with liver regeneration 1 accelerates hepatocyte proliferation during liver regeneration by activating Wnt/β-catenin signaling.

Long Non-Coding RNA MALAT-1 Overexpression Predicts Tumor Recurrence of Hepatocellular Carcinoma after Liver Transplantation

Clinical Value and Function of Lncrna MALAT 1 in Hepatocellular Carcinoma : a Comprehensive Study with Original Detection , Meta-Analysis and in Vitro Verification

LncRNA MALAT1 cessation antagonizes hypoxia/reoxygenation injury in hepatocytes by inhibiting apoptosis and inflammation via the HMGB1-TLR4 axis

An Integrated Transcriptomics and Proteomics Analysis Implicates lncRNA MALAT1 in the Regulation of Lipid Metabolism

Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development

LncRNA MALAT1 Aggravated Hepatic Ischemia-Reperfusion Injury via Activating the Severe Autophagy Pathway in Mice

The Long Non-Coding RNA MALAT1 Promotes the Migration and Invasion of Hepatocellular Carcinoma by Sponging Mir-204 and Releasing SIRT1.

Regulatory Networks of LncRNA MALAT-1 in Cancer

MALAT1/ miR-1-3p-mediated BRF2 promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway

LncRNA MALAT1: A Potential Regulator of Autophagy in Myocardial Ischemia-Reperfusion Injury

Long noncoding RNA MALAT-1: A versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance

Research Progress on a Long Non-coding RNA MALAT1

Long non-coding RNA MALAT1 aggravated liver ischemia-reperfusion injury via targeting miR-150-5p/AZIN1

Functions and regulatory mechanisms of metastasis-associated lung adenocarcinoma transcript 1.

LncRNA MALAT1 Functions As a Competing Endogenous RNA to Regulate ZEB2 Expression by Sponging Mir-200S in Clear Cell Kidney Carcinoma

Long Noncoding RNA Metastasis‐associated Lung Adenocarcinoma Transcript 1 Cooperates with Enhancer of Zeste Homolog 2 to Promote Hepatocellular Carcinoma Development by Modulating the Microrna‐22/snail Family Transcriptional Repressor 1 Axis

Sp1 Cooperates with Sp3 to Upregulate MALAT1 Expression in Human Hepatocellular Carcinoma.